Xconomy National

Archives

by in
Entry Author Date Location
Cheezburger CEO Ben Huh’s Amazing Story of Survival Curt Woodward 12/01/11 Seattle
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases Arlene Weintraub 10/18/11 Boston
PureTech Ventures Launches Tal Medical To Develop Magnetic-Field Treatment for Depression Arlene Weintraub 06/13/11 Boston
Prexa Pulls In $7M From Advent, Shire Erin Kutz 05/11/11 Boston
Why Are Drugs Getting Such Weird Brand Names? Luke Timmerman 05/09/11 National
Clinical Data’s Billionaire Chairman a Major Player in Firm’s Newly FDA-Approved Antidepressant Ryan McBride 01/25/11 Boston
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients Luke Timmerman 11/09/10 San Diego
BrainCells Inc. Buys Neuro Drug Luke Timmerman 08/04/10 San Diego
Oclaro Buys Mintera, Gazelle Gets $12M, Genzyme Buyout Rumors Swirl, & More Boston-Area Deals News Erin Kutz 07/28/10 Boston
Taris Hires New CEO, Stromedix Hopes Clinical Trial Will Advance, Euthymics Hits the Ground With Series A, & More Boston-Area Life Sciences News Erin Kutz 07/23/10 Boston
Euthymics, Led by Orexigen Vet, Nabs $24M for Depression Drug With Fewer Side Effects Luke Timmerman 07/22/10 Boston
Brain Cells’ Antidepressant Disappoints in Clinical Study, Otonomy Hears the Sound of Money, Cognionics Wins Startup Competition, & More San Diego Life Sciences News Denise Gellene 06/17/10 San Diego
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News Erin Kutz 06/16/10 Boston
Clinical Data Closes $32M Offering Ryan McBride 06/14/10 Boston
BrainCells Inc, With Novel Depression Drug, Seeks a Way Forward After Mixed Result Luke Timmerman 06/14/10 San Diego
eCBT Trauma Tracks PTSD Symptoms Erin Kutz 03/30/10 National
PatientsLikeMe Growing as Pharma Customers Boost Focus on Patients Ryan McBride 02/10/10 Boston
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood Luke Timmerman 02/04/10 Boston
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug Luke Timmerman 02/02/10 San Diego
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood Luke Timmerman 01/19/10 Boston
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting Gregory T. Huang 11/06/09 Seattle
Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete Luke Timmerman 09/02/09 San Diego
BrainCells Inc., Defying Convention, Suggests Novel Drug Combination Can Treat Depression Luke Timmerman 08/03/09 San Diego
BrainCells Depression Drug Reaches Goal Luke Timmerman 07/27/09 San Diego
Psylin Neurosciences—-Amylin’s Pysch-Drug Offspring—Nearing First Clinical Trial Ryan McBride 04/27/09 San Diego
FDA Rejects Somaxon’s Application for Insomnia Drug Bruce V. Bigelow 02/26/09 San Diego
Arena Weight Loss Drug Approaches Critical Turning Point Next Month Luke Timmerman 02/11/09 San Diego
TheraGenetics Bought by Avacta Luke Timmerman 01/29/09 Boston
Cypress Bioscience Shares Soar on News of FDA Approval Bruce V. Bigelow 01/15/09 San Diego
Northstar Neuroscience Shuts Down, Ending Experimental Depression Trial Luke Timmerman 01/05/09 Seattle
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.